Retour
Fourchette du Jour
24,01 €
25,41 €
Fourchette 52 Semaines
8,02 €
27,72 €
Volume
6 816 204
Moyenne 50J / 200J
24,58 €
/
20,18 €
Clôture Précédente
24,44 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -53,4 | 0,3 |
| P/B | 1,9 | 2,9 |
| ROE % | -3,7 | 3,7 |
| Net Margin % | -4,9 | 3,8 |
| Rev Growth 5Y % | -0,3 | 10,0 |
| D/E | 0,6 | 0,2 |
Objectif de Cours des Analystes
Hold
27,88 €
+11.9%
Low: 22,00 €
High: 30,00 €
P/E Prévisionnel
23,7
BPA Prévisionnel
1,03 €
Croissance BPA (est.)
+0,0%
CA Est.
5 B
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
1,53 €
1,50 € – 1,54 €
|
6 B | 2 |
| FY2029 |
1,44 €
1,42 € – 1,45 €
|
5,8 B | 4 |
| FY2028 |
1,33 €
0,36 € – 2,38 €
|
5,5 B | 6 |
Points Clés
Revenue declined -0,26% annually over 5 years
Earnings declined -168,64% over the past year
Generating 284,00M in free cash flow
PEG of 0,29 suggests growth is underpriced
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 6,48%
Capital efficient — spends only 5,85% of revenue on capex
Croissance
Revenue Growth (5Y)
-0,26%
Revenue (1Y)6,22%
Earnings (1Y)-168,64%
FCF Growth (3Y)55,80%
Qualité
Return on Equity
-3,67%
ROIC1,79%
Net Margin-4,92%
Op. Margin5,34%
Sécurité
Debt / Equity
0,61
Current Ratio2,17
Interest Coverage1,15
Valorisation
P/E Ratio
-53,40
P/B Ratio1,89
EV/EBITDA62,94
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 6,22% | Revenue Growth (3Y) | 3,32% |
| Earnings Growth (1Y) | -168,64% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -0,26% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 4,72B | Net Income (TTM) | -232,00M |
| ROE | -3,67% | ROA | -1,74% |
| Gross Margin | 43,48% | Operating Margin | 5,34% |
| Net Margin | -4,92% | Free Cash Flow (TTM) | 284,00M |
| ROIC | 1,79% | FCF Growth (3Y) | 55,80% |
| Safety | |||
| Debt / Equity | 0,61 | Current Ratio | 2,17 |
| Interest Coverage | 1,15 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -53,40 | P/B Ratio | 1,89 |
| P/S Ratio | 2,63 | PEG Ratio | 0,29 |
| EV/EBITDA | 62,94 | Dividend Yield | 0,00% |
| Market Cap | 12,39B | Enterprise Value | 15,86B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 4,72B | 4,44B | 4,42B | 4,41B | 4,76B |
| Net Income | -232,00M | 338,00M | -1,23B | -78,00M | -483,00M |
| EPS (Diluted) | -0,47 | 0,68 | -2,50 | -0,15 | -0,97 |
| Gross Profit | 2,05B | 1,91B | 1,94B | 1,97B | 2,08B |
| Operating Income | 252,00M | 251,00M | 326,00M | 384,00M | 304,00M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 13,36B | 12,61B | 14,36B | 15,49B | 16,48B |
| Total Liabilities | 6,81B | 6,52B | 8,14B | 8,20B | 8,97B |
| Shareholders' Equity | 6,55B | 6,10B | 6,22B | 7,29B | 7,51B |
| Total Debt | 4,02B | 4,32B | 5,77B | 5,84B | 6,32B |
| Cash & Equivalents | 545,00M | 468,00M | 352,00M | 345,00M | 638,00M |
| Current Assets | 3,46B | 3,22B | 3,41B | 3,28B | 3,27B |
| Current Liabilities | 1,60B | 1,32B | 1,24B | 1,70B | 1,65B |